Cargando…
Consensus statement of the Spanish Society of Internal Medicine and the Spanish Society of Medical Oncology on secondary thromboprophylaxis in patients with cancer
Up to 20% of cancer patients will develop some manifestation of venous thromboembolic disease (VTD) during their clinical course. VTD greatly impacts morbidity, mortality, quality of life and pharmaceutical expenditure. In addition, both thrombotic relapse and major haemorrhages derived from VTD tre...
Autores principales: | Quintanar, T., Font, C., Gallardo, E., Barba, R., Obispo, B., Díaz-Pedroche, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979662/ https://www.ncbi.nlm.nih.gov/pubmed/32885400 http://dx.doi.org/10.1007/s12094-020-02477-6 |
Ejemplares similares
-
Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
por: Remon, J., et al.
Publicado: (2019) -
Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in breast cancer
por: Ayala de la Peña, F., et al.
Publicado: (2021) -
Correction to: Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
por: Remon, J., et al.
Publicado: (2020) -
Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology
por: Colomer, R., et al.
Publicado: (2017) -
Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology
por: García-Alfonso, P., et al.
Publicado: (2020)